537
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

A review of the cohorts with environmental and occupational mineral fiber exposure

, , MD &
Pages 76-84 | Received 29 Sep 2017, Accepted 17 Apr 2018, Published online: 16 May 2018

References

  • Park EK, Takahashi K, Hoshuyama T, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119:514–518. doi:10.1289/ehp.1002845. PMID:21463977.
  • Bibby AC, Tsim S, Kanellakis N, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016;25:472–486. doi:10.1183/16000617.0063-2016. PMID:27903668.
  • Singh SD, Henley SJ, Ryerson AB. Summary of notifiable noninfectious conditions and disease outbreaks: surveillance for cancer incidence and mortality-United States, 2011. MMWR Morb Mortal Wkly Rep. 2015;62:11–51. doi:10.15585/mmwr.mm6254a3. PMID:26506286.
  • Geltner C, Errhalt P, Baumgartner B, et al. Austrian Mesothelioma Interest Group (AMIG). Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging consensus of the Austrian Mesothelioma Interest Group (AMIG). Wien Klin Wochenschr. 2016;128:611–617. doi:10.1007/s00508-016-1080-z. PMID:27619223.
  • Bianchi C, Bianchi T. Global mesothelioma epidemic: trend and features. Indian J Occup Environ Med. 2014;18:82–88. doi:10.4103/0019-5278.146897. PMID:25568603.
  • Carbone M, Ly BH, Dodson RF, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227:44–58. doi:10.1002/jcp.22724. PMID:21412769.
  • World Health Organisation. Environmental health criteria. In: Chrysotile Asbestos. Geneva: WHO; 1996. http://www.who.int/ipcs/assessment/public_health/chemicals_phc (Accessed 12 Apr 2017).
  • Baris YI, Sahin AA, Ozesmi M, et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain / Urgüp in Anatolia. Thorax. 1978;33:181–192. doi:10.1136/thx.33.2.181. PMID:663877.
  • Hillerdal G. Mesothelioma: cases associated with non – occupational and low dose exposure. Occup Environ Med. 1999;56:505–513.doi:10.1136/oem.56.8.505.PMID:10492646.
  • Soeberg MJ, van Zandwijk N. Asbestos and malignant pleural mesothelioma. In: Mineo TC, eds. Malignant Pleural Mesothelioma. Present Status and Future Directions. Vol. 1st ed. Sharjah, UAE: Bentham Science Publishers; 2016:115–28.
  • Plato N, Martinsen JI, Sparen P, Hillerdal G, Weiderpass E. Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban. Epidemiol Health. 2016;38:e2016039. doi:10.4178/epih.e2016039. PMID:27866405.
  • Liu B, van Gerwen M, Bonassi S, Taioli E. International association for the study of lung cancer mesothelioma task force. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12:1031–1045. doi:10.1016/j.jtho.2017.04.002. PMID:28412495.
  • Carbone M, Kanodia S, Chao A, et al. Consensus report of the 2015 Wienman international conference on mesothelioma. J Thorac Oncol. 2016;11:1246–1262. doi:10.1016/j.jtho.2016.04.028. PMID:27453164.
  • Metintas M. Turkey asbestos control strategic plan final report. Turk Thorac J. 2015;16:S1–S26. PMID:29404105.
  • Metintas M, Ozdemir N, Hillerdal G, et al. Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med. 1999;93:349–355. doi:10.1016/S0954-6111(99)90318-9. PMID:10464903.
  • Selçuk ZT, Cöplü L, Emri S, Kalyoncu AF, Sahin AA, Bariş YI. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest. 1999;102:790–796. doi:10.1378/chest.102.3.790.
  • Burdorf A, Heederik D. Applying quality criteria to exposure in asbestos epidemiology increases the estimated risk. Ann Occup Hyg. 2011;55:565–568. PMID:21742624.
  • Metintas S, Metintas M, Ucgun I, Oner U. Malignant mesothelioma due to environmental exposure to asbestos. Follow-up of a Turkish cohort living in a rural area. Chest. 2002;122:2224–2229. doi:10.1378/chest.122.6.2224. PMID:12475867.
  • Metintas S, Metintas M, Ak G, Kalyoncu C. Environmental asbestos exposure in rural Turkey and risk of lung cancer. Int J Environ Health Res. 2012;22:468–479. doi:10.1080/09603123.2011.654330. PMID:22300246.
  • Metintas M, Hillerdal G, Metintas S, Dumortier P. Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors. Arch Environ Occup Health. 2010;65:86–93. doi:10.1080/19338240903390305. PMID:20439227.
  • Metintas M, Hillerdal G, Metintas S. Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort. Eur Respir J. 1999;13:523–526. doi:10.1183/09031936.99.13352399. PMID:10232420.
  • Langer AM, Nolan RP, Constantopoulos SH, Moutsopoulos HM. Association of Metsovo lung and pleural mesothelioma with exposure to tremolite containing whitewash. Lancet. 1987;1:965–967. doi:10.1016/S0140-6736(87)90305-9. PMID:2882352.
  • Sakellariou K, Malamou-Mitsi V, Haritou A, et al. Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic? Eur Respir J. 1996;9:1206–1210. doi:10.1183/09031936.96.09061206. PMID:8804939.
  • Gogali A, Manda-Stachouli C, Ntzani EE, et al. Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later. Eur Respir J. 2012;39:217–219. doi:10.1183/09031936.00017011. PMID:22210814.
  • Constantopoulos SH. Environmental mesothelioma associated with tremolite asbestos: lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus. Regul Toxicol Pharmacol. 2008;52:S110–115. doi:10.1016/j.yrtph.2007.11.001. PMID:18171598.
  • Gasparrini A, Pizzo AM, Gorini G, et al. Prediction of mesothelioma and lung cancer in a cohort of asbestos exposed workers. Eur J Epidemiol. 2008;23:541–546. doi:10.1007/s10654-008-9257-z. PMID:18438715.
  • pt?>Magnani C, Ferrante D, Barone-Adesi F, et al. Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers. Occup Environ Med. 2007;65:164–170. doi:10.1136/oem.2007.032847. PMID:17704197.
  • Alies Patin AM, Valleron AJ. Mortality of workers in a French asbestos cement factory 1940–82. Br J Ind Med. 1985;42:219–225. PMID:2983751.
  • Lacourt A, Gramond C, Rolland P, et al. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 2014;69:532–539.doi:10.1136/thoraxjnl-2013-203744. PMID:24508707.
  • Lacourt A, Leffondre K, Gramond C, et al. Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma. Eur Respir J. 2012;39:1304–1312. doi:10.1183/09031936.00005111. PMID:22075480.
  • Frost G. The latency period of mesothelioma among a cohort of British asbestos workers (1978–2005). Br J Cancer. 2013;109:1965–1973. doi:10.1038/bjc.2013.514. PMID:23989951.
  • Berry G, Newhouse ML. Mortality of workers manufacturing friction materials using asbestos. Br J Ind Med. 1983;40:1–7. PMID:6297532.
  • Kielkowski D, Nelson G, Rees D. Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a African mortality study. Occup Environ Med. 2000;57:563–567. doi:10.1136/oem.57.8.563. PMID:10896964.
  • Sluis-Cremer GK, Liddell FDK, Logan WPD, Bezuidenhout BN. The mortality of amphibole miners in South Africa, 1946–80. Br J Ind Med. 1992;49:566–575. PMID:1325180.
  • Ndlovu N, teWater Naude J, Murray J. Compensation for environmental asbestos-related diseases in South Africa: a neglected issue. Glob Health Action. 2013;6:8–88.
  • Rees D, Myers JE, Goodman K, et al. Case – control study of mesothelioma in South Africa. Am J Ind Med. 1999;35:213–222. doi:10.1002/(SICI)1097-0274(199903)35:3%3c213::AID-AJIM1%3e3.0.CO;2-R. PMID:9987554.
  • McDonald AD, Case BW, Churg A, et al. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg. 1997;41:707–719. doi:10.1016/S0003-4878(97)00020-3. PMID:9375529.
  • Adib G, Labreche F, de Guire L, Dion C, Dufresne A. Short, fine and WHO asbestos fibers in the lungs of Quebec workers with an asbestos – related disease. Am J Ind Med. 2013;56:1001–1014. doi:10.1002/ajim.22180. PMID:23532794.
  • Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Eng J Med. 1998;338:1565–1571. doi:10.1056/NEJM199805283382201.
  • Sullivan PA. Vermiculite, respiratory disease, and asbestos exposure in libby, Montana: update of a cohort mortality study. Environ Health Perspect. 2007;115:579–585. doi:10.1289/ehp.9481. PMID:17450227.
  • Armstrong BK, de Klerk NH, Musk AW, Hobbs MST. Mortality in miners and millers of crocidolite in Western Australia. Br J Ind Med. 1988;45:5–13. PMID:2829959.
  • Reid A, de Klerk NH, Magnani C, et al. Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax. 2014;69:843–850. doi:10.1136/thoraxjnl-2013-204161. PMID:24842786.
  • Berry G, Reid A, Aboagye-Sarfo P, et al. Malignant mesothelioma in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up. Br J Can. 2012;106:1016–1020. doi:10.1038/bjc.2012.23.
  • Reid A, Heyworth J, de Klerk NH, Musk B. Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia. Int J Cancer. 2008;122:2337–2344. doi:10.1002/ijc.23331. PMID:18098288.
  • Bruno C, Tumino R, Fazzo L, et al. Incidence of pleural mesothelioma in a community exposed to fibres with fluoro-edenitic composition in Biancavilla (Sicily, Italy). Ann Ist Super Sanita. 2014;50:111–118. PMID:24968908.
  • Luo S, Liu X, Mu S, Tsai SP, Wen CP. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med. 2003;60:35–42. doi:10.1136/oem.60.1.35. PMID:12499455.
  • Baumann F, Maurizot P, Mangeas M, Ambrosi JP, Douwes J, Robineau B. Pleural mesothelioma in New Caledonia: associations with environmental risk factors. Environ Health Perspect. 2011;119:695–700. doi:10.1289/ehp.1002862. PMID:21193386.
  • Dodic-Fikfak M. An experiment to develop conversion factors to standardise measurements of airborne asbestos. Arh Hig Rada Toksikol. 2007;58:179–185. doi:10.2478/v10004-007-0003-9. PMID:17562601.
  • Huncharek M. Changing risk groups for malignant mesothelioma. Cancer. 1992;69:2704–2711. doi:10.1002/1097-0142(19920601)69:11%3c2704::AID-CNCR2820691113%3e3.0.CO;2-F. PMID:1571901.
  • Baumann F, Carbone M. Environmental risk of mesothelioma in the United States: an emerging concern – epidemiological issues. J Toxicol Environ Health B Crit Rev. 2016;19:231–249.doi:10.1080/10937404.2016.1195322. PMID:27705543.
  • Maher B. Fear in the dust. Nature. 2010;468:884–885. doi:10.1038/468884a. PMID:21164458.
  • Baumann F, Rougier Y, Ambrosi JP, Robineau BP. Pleural mesothelioma in New Caledonia: an acute environmental concern. Cancer Detection and Prev. 2007;31:70–76. doi:10.1016/j.cdp.2006.10.009.
  • Bourdes V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. European J Epidemiol. 2000;16:411–417. doi:10.1023/A:1007691003600.
  • Metintas M, Metintas S, Ak G, et al. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology. 2008;13:117–121. doi:10.1111/j.1440-1843.2007.01187.x. PMID:18197921.
  • Hansen J, De Klerk NH, Musk AW, et al. Environmental exposure to crocidolite and mesothelioma: exposure-response relationships. Am J Respir Crit Care Med. 1998;157:69–75.doi:10.1164/ajrccm.157.1.96-11086. PMID:9445280.
  • Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565–601. doi:10.1016/S0003-4878(00)00045-4. PMID:11108782.
  • Ferrante D, Mirabelli D, Tunesi S. Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case- control study with quantitative risk assessment. Occup Environ Med. 2016;73:147–153. doi:10.1136/oemed-2015-102803. PMID:26265669.
  • Pinto C, Ardizzoni A, Betta PG, et al. Expert opinions of the first Italian consensus conference on the management of malignant pleural mesothelioma. Am J Clin Oncol. 2011;34:99–109.doi:10.1097/COC.0b013e3181d31f02. PMID:20414089.
  • Reid A, Berry G, de Klerk N, et al. Age and sex differences in malignant mesothelioma after residential exposure to blue asbestos (crocidolite)*. Chest. 2007;131:376–382. doi:10.1378/chest.06-1690. PMID:17296636.
  • Oczypok EA, Sanchez MS, Van Orden DR, et al. Erionite-associated malignant pleural mesothelioma in Mexico. Int J Clin Exp Pathol. 2016;9:5722–5732.
  • Ortega-Guerrero MA, Carrasco-Nunez G, Barragan-Campos H, Ortega MR. High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in central Mexico. Occup Environ Med. 2015;72:216–218. doi:10.1136/oemed-2013-101957. PMID:25231672.
  • Hill RJ, Edwards RE, Carthew P. Early changes in the pleural mesothelium following intrapleural inoculation of the mineral fibre erionite and the subsequent development of mesotheliomas. J Exp Pathol. 1990;71:105–118.
  • McDonald JC, Harris JM, Berry G. Sixty years on: the price of assembling military gas masks in 1940. Occup Environ Med. 2006;63:852–855. doi:10.1136/oem.2006.028258. PMID:16984904.
  • Smith DD. Women and mesothelioma. Chest. 2002;122:1885–1886. doi:10.1378/chest.122.6.1885. PMID:12475820.
  • Baraldo S, Saetta M. Sex differences in airway anatomy over human lifespan. Eur Respir Mon. 2003;25:1–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.